Baxter raises forecasts for Hillrom synergies, allaying concerns over $10.5B takeover

Baxter increased its forecast for cost synergies from its $10.5 billion takeover of Hillrom announced in late 2021. The company now expects its pretax cost savings to rise to $300 million by 2024 compared to its original estimate of $250 million. The firm also said it should “realize up to $200 million in incremental annual revenue synergies” by 2025 and sales growth of 4% to 5% on a compounded annual basis from 2022 through 2025.